Douglas J. Williamson

Insider Reports History

Location
Dublin, Ireland
Signature
/s/ Austin D. Kim, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Douglas J. Williamson:

Form 4 holding Executive VP, Research & Dev

ACADIA PHARMACEUTICALS INC

Security class
Restricted Stock Units
Shares / value
50,655
Estimated value
$1,517,624
Report date
10 Feb 2023
Price
$29.96
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Medical Officer

AVADEL PHARMACEUTICALS PLC

Security class
Stock Option (Right to Buy)
Shares / value
275,000
Estimated value
Report date
14 Feb 2022
Price
Ownership
Direct
Underlying class
ADSs
Underlying amount
Form 4 holding Executive VP, Research & Dev

ACADIA PHARMACEUTICALS INC

Security class
Non-Qualified Stock Option (Right to Buy)
Shares / value
237,296
Estimated value
Report date
10 Feb 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Douglas J. Williamson

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .